- WHATS NEW?
- Suppression of chemokines by HDL
- HDL cholesterol linked to oestrogen levels
- New gene loci regulating HDL cholesterol identified
- Abnormal lipids when young predicts atherosclerosis in later life
- JUPITER: Is HDL cholesterol relevant to residual risk in low-risk patients on potent statin therapy?
- EAS Workshop: How does HDL protect against atherosclerosis?
Results of METEOR Trial: rosuvastin in low-risk patients
Rosuvastatin slowed progression of atherosclerosis at 2 years in people
with early signs of carotid artery disease and at low-risk of coronary
heart disease (CHD).
Corporate sponsor
